Clinical Trial Update: Polymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis.

View source ↗

Summary

A clinical trial update examining how polymorphisms in interleukin, glypican, and HLA genes influence treatment response in relapsing-remitting multiple scleros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Instituto Jalisciense de Cancerologia | Conditions: Multiple Sclerosis, Relapsing-Remitting | Status: UNKNOWN